Related Experiment Video
Updated: Mar 27, 2026

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Epigenetic Alterations in Alzheimer's Disease
Jose V Sanchez-Mut1, Johannes Gräff1
1Neuroepigenetics Laboratory - UPGRAEFF, Brain Mind Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne Lausanne, Switzerland.
Alzheimer's disease (AD) involves epigenetic alterations, particularly DNA hypermethylation and histone deacetylation, leading to reduced brain plasticity. Understanding these epigenetic changes is crucial for developing effective therapeutic strategies against AD.
Area of Science:
- Neuroscience
- Genetics
- Epigenetics
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, often diagnosed late when treatments are ineffective.
- Most AD cases lack strong genetic links, suggesting non-genetic factors play a significant role.
- Epigenetic mechanisms integrate environmental influences with genetic predispositions.
Purpose of the Study:
- To review recent findings on epigenetic alterations in Alzheimer's disease.
- To discuss technical and methodological considerations for interpreting epigenetic studies in AD.
- To outline future research directions for understanding epigenetic contributions to AD.
Main Methods:
- Review of existing literature on epigenetic mechanisms in AD.
- Analysis of genome-wide and locus-specific epigenetic alterations reported in AD.
- Discussion of mutations in epigenetic enzymes and their link to neurodegeneration.
Main Results:
- Epigenetic dysregulation is increasingly implicated in AD, especially in aging.
- Mutations in epigenetic machinery enzymes are linked to neurodegenerative processes in AD.
- AD is associated with DNA hypermethylation and histone deacetylation, indicating a repressed chromatin state.
Conclusions:
- Epigenetic alterations, including DNA hypermethylation and histone deacetylation, contribute to AD pathogenesis.
- A repressed chromatin state and reduced epigenetic plasticity are characteristic of AD.
- Further research into epigenetic mechanisms is vital for developing novel AD therapies.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Epigenetic Regulation
X-chromosome...